Hanfling is research coordinator for Rachel Rubin MD PLLC and a medical student at the University of Maryland School of Medicine.
Moving LiSWT into formal postpartum care guidelines will require randomized controlled trials with adequate sample sizes, defined treatment parameters, long-term follow-up, and dedicated safety data in lactating patients, with cost-effectiveness analysis also identified as a priority research direction.
LiSWT may offer a noninvasive option for postpartum pelvic pain, with potential benefits across both chronic and earlier-stage scar-related dysfunction.
A case report describes the first known use of low-intensity extracorporeal shock wave therapy for episiotomy scar pain, with a patient reporting meaningful improvement after more than 20 years of chronic pelvic floor dysfunction.
